Community perceptions of barriers to management of chronic psychotic disorders and knowledge and attitudes about long-acting injectable antipsychotic medication: qualitative study in Dar es Salaam, Tanzania

BJPsych Open
Carol BlixenMartha Sajatovic

Abstract

Low- and middle-income countries (LMICs) experience a disproportionate burden from chronic psychotic disorders (CPDs), which are the most disabling conditions among people aged 10-24 in Sub-Saharan Africa. Poor medication adherence is seen in approximately half of individuals with CPDs in Sub-Saharan Africa, and is a major driver of relapse. A CPD treatment approach that combines the use of long-acting injectable (LAI) antipsychotic medications with a brief and practical customised adherence-enhancement behavioural intervention (CAE-L) was recently developed and tested for use in the USA. To use a qualitative cross-sectional analysis to gather information on potentially modifiable barriers to management of CPDs, and assess attitudes about LAIs from community participants in Tanzania. Findings were intended to refine the CAE-L curriculum for use in Tanzania. In-depth interviews and focus groups were conducted with 44 participants (patients with CPD, caregivers, mental healthcare providers). All interviews and focus groups were audiotaped, translated, transcribed and analysed using content analysis, with an emphasis on dominant themes. Findings indicated that promoting medication adherence and management of CPDs in the Tanzanian ...Continue Reading

References

Jan 1, 1988·Health Education Quarterly·K R McLeroyK Glanz
Mar 31, 1998·The British Journal of Psychiatry : the Journal of Mental Science·M Knapp
Nov 25, 2003·The Journal of Clinical Psychiatry·Teresa A PigottUNKNOWN Aripiprazole Study Group
Jun 3, 2004·The British Journal of Psychiatry : the Journal of Mental Science·Martin KnappPablo Lapuerta
Oct 20, 2004·The American Psychologist·Patrick Corrigan
May 27, 2005·PLoS Medicine·Sukanta SahaJohn McGrath
Nov 3, 2006·Qualitative Health Research·Maria H F Grypdonck
Feb 9, 2007·Health Services Research·Elizabeth H BradleyKelly J Devers
May 29, 2007·Journal of Strength and Conditioning Research·James E Leone, Joyce V Fetro
Jun 21, 2007·Schizophrenia Bulletin·Steven C Marcus, Mark Olfson
Sep 18, 2007·International Journal for Quality in Health Care : Journal of the International Society for Quality in Health Care·Allison TongJonathan Craig
Jan 2, 2009·The British Journal of Psychiatry : the Journal of Mental Science·Ademola B AdeponleLaurence J Kirmayer
Apr 28, 2009·International Journal of Public Health·Vikram Patel
Jan 29, 2014·Global Health Promotion·Vincent O Onywera, Claire Blanchard
Apr 1, 2013·Journal of Research in Pharmacy Practice·Jonathan DanladiHafsat O Jimoh
May 26, 2017·International nursing review·S ChidarikireM Cleary

❮ Previous
Next ❯

Citations


❮ Previous
Next ❯

Related Concepts

Related Feeds

Antipsychotic Drugs

Antipsychotic drugs are a class of medication primarily used to manage psychosis (including delusions, hallucinations, paranoia or disordered thought), principally in schizophrenia and bipolar disorder. Discover the latest research on antipsychotic drugs here